Bolivia IFU and Manuals: Spanish-Language Requirements for Medical Devices
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
Section 2.7 of the Manual requires the operation manual, maintenance manual and installation manual to be in Spanish. These are three independent manuals, not one leaflet with three chapters. Section 2.9 adds that for biomedical equipment, manuals must be provided in both the original language and Spanish. GRZAN’s assessment is that Bolivia’s definition of manuals is broader than what companies in China normally prepare: a single instructions-for-use document, or IFU, is not sufficient to satisfy Section 2.7. For biomedical equipment, the workload doubles, because the original-language versions must accompany the Spanish ones. Companies that plan the Spanish documentation effort on the assumption of one translated booklet will underestimate both the translation volume and the review risk, since a dossier that presents only an IFU where three manuals are required will be flagged as incomplete at screening. The correct starting point is a document inventory by type and language, agreed before translation begins. The distinction matters operationally: each manual has a different audience, a different update cycle and a different owner inside the organization. The inventory should also fix the cost baseline, because scope changes mid-project are the main driver of budget overruns in localization work. The inventory should record, for each document, its language status and the date of its latest revision.
2. Legal basis
| Regulation | Reference number | Publication date | Provision |
|---|---|---|---|
| Manual para Registro Sanitario de Dispositivos Médicos | Resolución Ministerial N° 010 | Current version as published on the AGEMED website | Section 2.7 |
| Manual para Registro Sanitario de Dispositivos Médicos | Resolución Ministerial N° 010 | Current version as published on the AGEMED website | Section 2.9 |
| Manual para Registro Sanitario de Dispositivos Médicos | Resolución Ministerial N° 010 | Current version as published on the AGEMED website | Section 2.4 |
| Manual para Registro Sanitario de Dispositivos Médicos | Resolución Ministerial N° 010 | Current version as published on the AGEMED website | Section 2.5 |
3. Expert insights
Insight one: the three manual types correspond to three use scenarios. The operation manual is addressed to clinical users, the maintenance manual to service engineers, and the installation manual to the personnel who set up the equipment. Section 2.7 lists them side by side, which shows that AGEMED’s concern is controllability of the product across its entire use cycle, not merely the end-user stage. A device that can be operated but not serviced or correctly installed by Spanish-speaking personnel remains a safety concern in the regulator’s view. Companies should therefore audit which of the three documents actually exist in their documentation system before translating, since in many organizations the installation and maintenance content is scattered across service bulletins rather than assembled into standalone manuals. Templates from other markets rarely contain the three-part structure, so a gap analysis against the three manual types is the correct first step. Where a manual does not yet exist in any language, writing it is part of the registration project, and its timeline should be planned accordingly rather than discovered at translation. The three audiences also justify different levels of technical detail, which is why a single combined manual tends to serve none of them well.
Insight two: the dual-language requirement for biomedical equipment is a costly commitment. Section 2.9 requires both the original-language and Spanish versions of the manuals. Together with the 5-year spare parts and maintenance commitment and the training commitment under the same section, it forms a package of proof that the equipment can remain in service over the long term. Companies should include translation and localized training costs in their pricing at the quotation stage, not discover them after the contract is signed. The dual-language set also creates a maintenance obligation: when the original manual is revised, the Spanish version must be kept aligned, or the registered documentation set drifts out of date. The revision workflow should be planned so that both language versions are released together, keeping the registered set coherent, and the duty to keep documents current should be defined between the parties in the distribution agreement.
Insight three: the IFU summary in the technical file and the full manuals are two distinct requirements. Section 2.4 requires the technical documentation to include a summary of instructions for use, while Section 2.7 requires the complete three Spanish manuals. Neither can substitute for the other: the summary goes into the technical file as a condensed description, and the complete manuals stand alone as separate bound documents. Confusing the two, for example by inserting the full manual into the technical file and omitting the standalone set, produces a dossier that looks voluminous but fails the structural requirement. The summary should be drafted as a standalone document, checked against the manuals for consistency, and updated whenever the manuals change.
4. Practical recommendations
- Prepare Spanish manuals separately for the operation, maintenance and installation types, and do not substitute a single IFU for the three-document set.
- For biomedical equipment, additionally prepare the original-language versions, and reserve the costs of translation, training and spare parts fulfilment in the project budget.
- Compile the summary of instructions for use separately, distinct from the complete manuals, and place it in the technical documentation where Section 2.4 requires it.
- Establish version control across languages, so that every revision to the original manual triggers a corresponding revision of the Spanish set, so that both language versions are released together.
5. Verification checklist
- □ The operation manual has a Spanish version
- □ The maintenance manual has a Spanish version
- □ The installation manual has a Spanish version
- □ Biomedical equipment is provided with the original-language versions as well
- □ The summary of instructions for use has been compiled separately in the technical documentation
Regulatory information verified as of October 29, 2026.
GRZAN provides registration support in Bolivia for manufacturers, importers and authorized representatives, covering Spanish documentation, manual localization, dossier assembly and regulatory correspondence. For assistance with manual requirements and the full registration process, contact info@grzanglobal.com. Support covers both standard devices and biomedical equipment with dual-language obligations, and confirms each document is complete before translation begins.
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us